Gene Therapy In Oncology Market Research Report- Ken Research

1
Gene Therapy In Oncology Market Research Report-
Ken Research
2

• 
  Summary
• In this report, Global Data provides an overview
  of the current competitive landscape of gene
  therapies in multiple oncology indications, the
  regulatory framework concerning their clinical
  development and commercialization in the 8MM (US,
  France, Germany, Italy, Spain, UK, Japan, and
  China).

3

• Gene therapy combines reduced treatment duration
  with a higher chance of cure unlike conventional
  oncology treatments such as chemotherapy. However
  this novel therapeutic approach requires the
  delivery of genetic material to the patient, an
  uncharted territory in oncology which will
  necessitate the implementation of new regulatory
  guidelines and the restructuring of existing
  treatment algorithms in various oncology
  indications.
• The current clinical development of gene
  therapies in oncology is dominated by small size
  biotech and pharmaceutical companies. Astrazeneca
  is the only large pharmaceutical company with an
  in-house gene therapy in late stage clinical
  development. Other major players such as johnson
  johnson have the exclusive worldwide rights to
  develop and commercialize gerons imetelstat,
  while merck co. And bms are evaluating their
  respective checkpoint inhibitor therapies with
  many of the phase iii and phase ii candidates in
  the cancer gene therapy pipeline..

4

• Develop business strategies by understanding the
  trends shaping and driving the gene therapy in
  the oncology space in the 8mm. Formulate
  effective sales and marketing strategies by
  understanding the current competitive landscape
  and by analyzing the portfolios of various
  competitors. Identify areas of unmet need within
  the cancer gene therapy market to help drive
  research and development towards future market
  opportunities.
• Gain insights to help plan and design your
  clinical trials. Organize your sales and
  marketing efforts by identifying the market
  categories and segments that present maximum
  opportunities for consolidations, investments,
  and strategic partnerships. Identify key pricing
  and reimbursement strategies.

5

• Despite the gradual increase in electronic
  payments, cash still remains as the preferred
  mode of payment accounting for more than
  two-thirds of the transactions in the country by
  cash. Various government initiatives like the Act
  Governing Electronic Payments Institutions are
  encouraging Taiwanese to make electronic
  payments. Though debit cards are used widely,
  they are limited merely to cash withdrawals at
  ATMs.
• To encourage the use of credit cards, many public
  banks have waived transaction fees. Various other
  market players like Apple Pay, Samsung Pay,
  Google Pay were also recently launched to drive
  the demand in the market.

6

• Browse Full Market Report
• Gene Therapy in Oncology
• Related reports
• Gene Therapy in CVMD
• PharmaSphere Emerging Biotechnologies-Gene
  Therapy Market Analysis

7
About Ken Research

• Ken Research provides bespoke industry
  intelligence, equity research reports and
  business consulting services on gamut of sectors
  across the globe. We use advanced information
  management tools, sophisticated analytical
  systems and methodologies to help our clients
  with crucial industry information for decision
  making.
• As a leading Online Market Research Report
  Seller, Ken Research act as a platform for
  accessing statistics, forecast, business
  insights, Ideas, concepts and much more.

8

• Contact Us
• Ken Research
• Ankur Gupta, Head Marketing Communications
• sales_at_kenresearch.com
• 91-9015378249

9
(No Transcript)